Clinical Implementation of CGM in the Community Pharmacy
The American Pharmacists Association (APhA) developed The Clinical Implementation of Continuous Glucose Monitoring in the Community Pharmacy Certificate Training Program, an educational experience designed to equip pharmacists with the knowledge, skills, and confidence needed to perform CGM services. The program has both an online home study component, as well as, a 4-hour live program.
The program provides comprehensive instruction in current CGM concepts and standards of care and incorporates case studies and hands-on skills training focused on the situations most likely to be encountered—as well as the services most needed—in community practice settings. Participants will gain experience in the clinical and operational aspects of CGM, including but not limited to workflow, billing, patient identification, patient education, visit guides, and documentation processes.
Offerings coming soon!
Learning Objectives
Module 1: Introduction to continuous glucose monitoring
At the completion of this activity, participants will be able to:
- Describe the importance of achieving glucose targets in people with types 1 and 2 diabetes (T1D and T2D).
- Compare and contrast traditional blood glucose monitoring, hemoglobin A1C, and continuous glucose monitoring (CGM) and the role each plays in patient care.
- Discuss the clinical value of CGM for people living with diabetes.
- Identify individuals that would benefit from CGM based on current clinical practice guidelines.
- Recall key outcomes data supporting use of CGM in select populations.
Module 2: Continuous glucose monitoring devices
At the completion of this activity, participants will be able to:
- Recognize continuous glucose monitoring (CGM) device types and components.
- Compare and contrast currently available CGM devices.
- Identify device- and patient-specific factors for selecting a CGM device
- Describe appropriate steps to operate and retrieve data from CGM devices.
Module 3: Evolution of continuous glucose monitoring: Integration with insulin delivery
At the completion of this activity, participants will be able to:
- Describe available insulin delivery systems that integrate with continuous glucose monitoring (CGM).
- Differentiate features of connected insulin pens and how they may be applied in clinical practice to optimize insulin therapy.
- Explain automated insulin delivery (AID) via pump systems that integrate with CGM.
- Discuss evidence on clinical outcomes for AID systems in people with diabetes.
Module 4: Continuous glucose monitoring targets and reports
At the completion of this activity, participants will be able to:
- Discuss key continuous glucose monitoring metrics and time in range (TIR) guidelines for multiple types of people with diabetes.
- Interpret continuous glucose monitoring (CGM) key metrics and Ambulatory Glucose Profile (AGP) reports.
Module 5: Troubleshooting continuous glucose monitoring technology
At the completion of this activity, participants will be able to:
- Identify potential user error and troubleshooting needed with continuous glucose monitoring (CGM) data.
- Discuss strategies to assist patients in resolving CGM-related issues.
Module 6: Medication adjustment and patient education based on continuous glucose monitoring data
At the completion of this activity, participants will be able to:
- Describe the DATAA model and how it can be used to facilitate shared decision making.
- Use the DATAA model to interpret CGM data and adjust treatment regimens.
- Apply CGM best practices through a series of patient cases.
- Demonstrate effective strategies for communicating the data report to the patient.
Module 7: Billing for continuous glucose monitoring devices and services
At the completion of this activity, participants will be able to:
- Identify available pharmacy payors for continuous glucose monitoring (CGM) devices.
- Identify opportunities for pharmacy payment for pharmacist-delivered CGM services.
- Describe best practices in billing for CGM devices and pharmacist-delivered CGM services.
Module 8: Continuous glucose monitoring business planning
At the completion of this activity, participants will be able to:
- Identify community and pharmacy-based metrics to utilize to evaluate potential plausibility from CGM services in your pharmacy.
- Describe the start-up process for CGM service delivery.
- Construct an effective, efficient pharmacy workflow for CGM service delivery.
- Recognize best practices and resources for staff training prior to CGM service delivery.
- Discuss marketing considerations for CGM service delivery.
Module 9: Optimizing continuous glucose monitoring access and efficiency
At the completion of this activity, participants will be able to:
- Describe the challenges and barriers to access for the effective use of continuous glucose monitoring.
- List examples of legislation related to pharmacists providing CGM services.
Live Program
At the completion of this activity, participants will be able to:
- Discuss an effective approach for identifying patients that may benefit from continuous glucose monitoring (CGM) services from your pharmacy.
- Operate a variety of CGM devices appropriately.
- Identify and troubleshoot potential issues with CGM device attachment.
- Analyze CGM reports and provide clinical recommendations based on CGM data.
- Practice educating patients based on CGM data using shared decision-making and motivational interviewing principles.
- Summarize CGM-related recommendations effectively for interdisciplinary providers and patients.
- Outline an implementation plan for CGM services in your pharmacy.
Accreditation Information
The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. APhA's Clinical Implementation of CGM in the Community Pharmacy certificate training program is approved for a total of 12.0 contact hours of continuing pharmacy education (CPE) credit (1.2 CEUs). The ACPE Universal Activity Numbers (UAN) for this activity are listed below.
-
Successful completion of the self-study component involves passing the self-study assessment with a grade of 70% or higher and will result in 8 contact hours of CPE credit (0.8 CEUs). ACPE UAN: 0202-0000-24-260-H01-P
-
Successful completion of the live component involves attending the full live seminar and completing the online assessment and evaluation. Successful completion of this component will result in 4 contact hours of CPE credit (0.4 CEUs). ACPE UAN: 0202-0000-24-261-L01-P / 0202-9999-24-261-L01-P
-
Release Date: July 1, 2024
-
Expiration Date: July 1, 2027 - PLEASE NOTE: NO Home Study credit granted after this date; Live Credit can only be granted within 60 days from the day of the session attended.
Development
The Clinical Implementation of CGM in the Community Pharmacy CTP is an education activity for pharmacists developed by the American Pharmacists Association and supported by an educational grant from The Leona M. and Harry B. Helmsley Charitable Trust. © 2024 American Pharmacists Association.
Acknowledgements:
Advisory Board
Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
Endocrine Clinical Pharmacy Specialist, Co-Director, Endocrine Disorders in Pregnancy
Cleveland Clinic Endocrinology & Metabolism Institute
Lindsey Miller, PharmD
Clinical Assistant Professor
University of Mississippi School of Pharmacy
Nicole C. Pezzino, PharmD, BCPS, CDCES
Associate Professor of Pharmacy Practice, Director of Community Outreach & Innovation, Director of PGY1 Community Pharmacy Residency Program
Wilkes University, Nesbitt School of Pharmacy